Healthcare provider profile · identity verified

Juancho Robles Libiran, M.D.

Internal Medicine · UNION CITY, CA · NPI 1114004074

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	534	194
Amlodipine Besylate	Amlodipine Besylate	392	134
Losartan Potassium	Losartan Potassium	386	130
Atenolol	Atenolol	226	80
Lisinopril	Lisinopril	211	77
Metformin Hcl	Metformin Hcl	196	72
Metformin Hcl Er	Metformin Hcl	167	59
Allopurinol	Allopurinol	146	53
Simvastatin	Simvastatin	144	47
Tamsulosin Hcl	Tamsulosin Hcl	137	52
Famotidine	Famotidine	128	51
Albuterol Sulfate Hfa	Albuterol Sulfate	121	43
Metoprolol Tartrate	Metoprolol Tartrate	102	33
Glipizide	Glipizide	95	41
Levothyroxine Sodium	Levothyroxine Sodium	93	34
Omeprazole	Omeprazole	88	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	27
Finasteride	Finasteride	81	31
Gabapentin	Gabapentin	77	31
Pantoprazole Sodium	Pantoprazole Sodium	75	38
Lovastatin	Lovastatin	72	20
Hydrochlorothiazide	Hydrochlorothiazide	71	25
Colchicine	Colchicine	69	29
Alendronate Sodium	Alendronate Sodium	68	22
Jardiance	Empagliflozin	68	23
Fluocinonide	Fluocinonide	65	26
Furosemide	Furosemide	65	25
Triamcinolone Acetonide	Triamcinolone Acetonide	62	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	22
Lorazepam	Lorazepam	57	16
Fluticasone Propionate	Fluticasone Propionate	56	22
Glipizide Er	Glipizide	52	17
Wixela Inhub	Fluticasone Propion/Salmeterol	51	13
Alvesco	Ciclesonide	49	17
Carvedilol	Carvedilol	43	15
Meloxicam	Meloxicam	42	23
Clopidogrel	Clopidogrel Bisulfate	39	12
Tramadol Hcl	Tramadol Hcl	39	13
Nifedipine Er	Nifedipine	38	15
Potassium Chloride	Potassium Chloride	35	14
Clonidine Hcl	Clonidine Hcl	34	12
Humulin N	Insulin Nph Human Isophane	33	15
Rosuvastatin Calcium	Rosuvastatin Calcium	32	11
Terazosin Hcl	Terazosin Hcl	32	13
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	30	12
Hydralazine Hcl	Hydralazine Hcl	29	12
Tizanidine Hcl	Tizanidine Hcl	29	24
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	14
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Ibuprofen	Ibuprofen	27	15
Ozempic	Semaglutide	27	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Temazepam	Temazepam	24	suppressed
Trazodone Hcl	Trazodone Hcl	24	11
Metoprolol Succinate	Metoprolol Succinate	22	suppressed
Humulin R	Insulin Regular, Human	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	21	suppressed
Prednisone	Prednisone	21	14
Baclofen	Baclofen	19	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	18	18
Propranolol Hcl	Propranolol Hcl	18	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Alprazolam	Alprazolam	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Cefadroxil	Cefadroxil	15	15
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Sertraline Hcl	Sertraline Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Azithromycin	Azithromycin	11	11
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error